Market Tracker

08/21 6:05pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

5.11
Data as of 3:59pm ET
 -0.08 / -1.54%
Today’s Change
4.40
Today|||52-Week Range
8.19
-15.82%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close5.19
Today’s open5.14
Day’s range5.06 - 5.21
Volume78,329
Average volume (3 months)69,429
Market cap$183.7M
Dividend yield--
Data as of 3:59pm ET, 08/21/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ELTPElite Pharmaceutical...0.000.00%
EBIOEleven Biotherapeuti...-0.17-1.49%
NAVBNavidea Biopharmaceu...+0.01+0.80%
INNLInnocoll AG-0.22-2.44%
Data as of 4:02pm ET, 08/21/2014

Financials

Next reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts